25mgx50 tablets/bottle National drug approval number H33021143

Ingredients:The main chemical component is atenolol. Chemical name is 4-[3-[(1-methylethyl)amino-2-hydroxy]propoxy]benzeneacetamide

Properties:This product is white tablets or sugar-coated tablets, white color after removing the sugar coating.

Indications:For the treatment of hypertension, angina pectoris, myocardial infarction, but also for arrhythmia, hyperthyroidism, pheochromocytoma.

Usage and dosage:Oral. Adults commonly used, start each time 6.25-12.5mg (1/4-1/2 tablets), twice a day, according to the need and tolerate the amount of increase and decrease to 50-200mg (2-8 tablets), see the instructions.

Adverse reactions:In patients with myocardial infarction, the most common adverse reactions are hypotension and bradycardia; other reactions may include dizziness, cold extremities, fatigue, malaise, gastrointestinal discomfort, depression, alopecia, thrombocytopenia, psoriasiform skin reactions, worsening of psoriasis, rash, and dry eyes. Rarely cause heart block in sensitive patients.

Contraindications:1 II-III degree heart block. 2 Those with cardiogenic shock. 3 Sick sinus syndrome and severe sinus bradycardia.

Specification:25mg

Packing specification:25mg*50 tablets/bottle

Expiry date:36 months